These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2005-000346-36||A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of LB03002, a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Daily The...||2010-06-07||due-trials|
|Listed as ongoing, but also has a completion date||2005-000384-26||A phase III, double-blind, randomized, placebo-controlled, parallel-group, multicenter study to assess efficacy and safety of LB03002 administered weekly in adults with growth hormone deficiency.||2008-03-04||bad-data|
|Listed as ongoing, but also has a completion date||2006-002278-24||A phase III, open-label, uncontrolled, multicentre, rollover study to assess safety and efficacy of LB03002 administered weekly in adults with growth hormone deficiency.||2008-09-05||bad-data|